Back

Tier-specific location of Lewy body pathology and related neuromelanin levels drive dopaminergic cell vulnerability in pigmented non-human primates

Chocarro, J.; Rico, A. J.; Ariznabarreta, G.; Lorenzo-Ramos, E.; Ilarduya, M. M.; Canales, C.; Leon-Villares, A.; Blesa, J.; Obeso, J. A.; Lanciego, J. L.

2026-04-01 neuroscience
10.64898/2026.03.30.715197 bioRxiv
Show abstract

Although a differential vulnerability of dopaminergic neurons to degeneration based on their specific location within the dorsal and ventral tiers of the substantia nigra pars compacta (SNcD and SNcV, respectively) has long been postulated, the underlying mechanisms sustaining these tier-specific differences remain poorly understood. Here, upon inducing a viral-mediated enhancement of neuromelanin (NMel) accumulation within dopaminergic neurons in non-human primates, the distribution of Lewy body-like inclusions (LBs) was analyzed within identified SNcD and SNcV neurons, together with their intracellular NMel levels. Results showed that the vast majority of intracytoplasmic inclusions were found in SNcV neurons, and indeed correlated to higher pigmentation levels. By contrast, only very few LBs were found in calbindin-positive neurons of the SNcD, which in parallel exhibited very low levels of NMel accumulation. These results postulate an additive effect made of a tier-specific location of LB burden together with high pigmentation levels as synergistic drivers sustaining the preferential vulnerability of SNcV dopaminergic neurons. Moreover, the evidence obtained here supported that NMel accumulation beyond a given threshold triggers the aggregation of endogenous -Syn in the form of LBs; therefore, approaches intended to reduce pigmentation levels in SNcV neurons would likely induce a neuroprotective effect by preventing the subsequent aggregation of -Syn.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Neurobiology of Disease
134 papers in training set
Top 0.2%
15.4%
2
npj Parkinson's Disease
89 papers in training set
Top 0.3%
10.9%
3
ACS Chemical Neuroscience
60 papers in training set
Top 0.1%
10.9%
4
Cells
232 papers in training set
Top 0.5%
3.8%
5
Neuroscience
88 papers in training set
Top 0.4%
2.9%
6
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.2%
7
Scientific Reports
3102 papers in training set
Top 49%
2.2%
8
Cell Death & Disease
126 papers in training set
Top 0.6%
2.2%
50% of probability mass above
9
Experimental Neurology
57 papers in training set
Top 0.5%
2.0%
10
Brain
154 papers in training set
Top 3%
1.9%
11
Frontiers in Neuroscience
223 papers in training set
Top 3%
1.9%
12
Translational Psychiatry
219 papers in training set
Top 3%
1.7%
13
eneuro
389 papers in training set
Top 6%
1.6%
14
Molecular Neurobiology
50 papers in training set
Top 0.4%
1.6%
15
Journal of Neuroinflammation
50 papers in training set
Top 0.5%
1.6%
16
Brain Research
35 papers in training set
Top 1.0%
1.4%
17
Progress in Neurobiology
41 papers in training set
Top 1%
1.4%
18
Neuroscience Bulletin
11 papers in training set
Top 0.4%
1.4%
19
Frontiers in Aging Neuroscience
67 papers in training set
Top 2%
1.3%
20
European Journal of Neuroscience
168 papers in training set
Top 0.7%
1.3%
21
PLOS ONE
4510 papers in training set
Top 59%
1.3%
22
Acta Neuropathologica
51 papers in training set
Top 0.9%
1.0%
23
Acta Neuropathologica Communications
81 papers in training set
Top 0.8%
1.0%
24
Journal of Parkinson's Disease
13 papers in training set
Top 0.3%
0.9%
25
Molecular Neurodegeneration
49 papers in training set
Top 0.7%
0.9%
26
Alzheimer's & Dementia
143 papers in training set
Top 2%
0.8%
27
Journal of Neurology
26 papers in training set
Top 1%
0.8%
28
Neurotherapeutics
11 papers in training set
Top 0.5%
0.8%
29
Brain Communications
147 papers in training set
Top 3%
0.8%
30
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.9%
0.8%